Recombinant Human α-1 antitrypsin (Healthgen Biotechnology)
重组人α1-抗胰蛋白酶（禾元生物）
Report date: 2024/11/29 20:00:39
Base Information
Drug NameRecombinant Human α-1 antitrypsin (Healthgen Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWuhan Healthgen Biotechnology Corp
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWuhan Healthgen Biotechnology Corp
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A